Kadimastem Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating industry group for Kadimastem Ltd are shown below. This ESG score for Kadimastem Ltd indicates the company's reporting of the United Nations SDGs. Complete Sustainability assessment of Kadimastem Ltd are accessed by signing in.
Kadimastem Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.2; made up of an environmental score of 4.0, social score of 2.7 and governance score of 0.0.
2.2
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1529 | Slang Worldwide Inc | 2.3 | Medium |
1529 | Vanda Pharmaceuticals Inc | 2.3 | Medium |
1551 | Kadimastem Ltd | 2.2 | Medium |
1551 | Brawn Biotech Ltd | 2.2 | Medium |
1551 | Pangaea Oncology SA | 2.2 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Kadimastem Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Kadimastem Ltd disclose current and historical energy intensity?
Does Kadimastem Ltd report the average age of the workforce?
Does Kadimastem Ltd reference operational or capital allocation in relation to climate change?
Does Kadimastem Ltd disclose its ethnicity pay gap?
Does Kadimastem Ltd disclose cybersecurity risks?
Does Kadimastem Ltd offer flexible work?
Does Kadimastem Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Kadimastem Ltd disclose the number of employees in R&D functions?
Does Kadimastem Ltd conduct supply chain audits?
Does Kadimastem Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Kadimastem Ltd conduct 360 degree staff reviews?
Does Kadimastem Ltd disclose the individual responsible for D&I?
Does Kadimastem Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Kadimastem Ltd disclose current and / or historical scope 2 emissions?
Does Kadimastem Ltd disclose water use targets?
Does Kadimastem Ltd have careers partnerships with academic institutions?
Did Kadimastem Ltd have a product recall in the last two years?
Does Kadimastem Ltd disclose incidents of discrimination?
Does Kadimastem Ltd allow for Work Councils/Collective Agreements to be formed?
Has Kadimastem Ltd issued a profit warning in the past 24 months?
Does Kadimastem Ltd disclose parental leave metrics?
Does Kadimastem Ltd disclose climate scenario or pathway analysis?
Does Kadimastem Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Kadimastem Ltd disclose the pay ratio of women to men?
Does Kadimastem Ltd support suppliers with sustainability related research and development?
Does Kadimastem Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Kadimastem Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Kadimastem Ltd involved in embryonic stem cell research?
Does Kadimastem Ltd disclose GHG and Air Emissions intensity?
Does Kadimastem Ltd disclose its waste policy?
Does Kadimastem Ltd report according to TCFD requirements?
Does Kadimastem Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Kadimastem Ltd disclose energy use targets?
Does Kadimastem Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Kadimastem Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Kadimastem Ltd
These potential risks are based on the size, segment and geographies of the company.
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was founded in 2008 and is based in Ness Ziona, Israel.